Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 4/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | FNTA | P49354 | 1/20 | 0.34 |
| ▸ | FNTB | P49356 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8756611 | 0.82 | ALOX15 (0.44) | ALOX15TDP1TSHRALDH1A1FNTA | |
| SCHEMBL16897675 | 0.80 | ALOX15 (0.51) | ALOX15TSHRALDH1A1USP2GLA | |
| SCHEMBL25689218 | 0.79 | ALOX15 (0.51) | ALOX15TDP1TSHRALDH1A1USP2 | |
| SCHEMBL11519762 | 0.79 | TDP1 (0.44) | TDP1TSHRALDH1A1USP2HPGD | |
| SCHEMBL17718252 | 0.79 | TDP1 (0.44) | TDP1TSHRALDH1A1USP2HPGD | |
| SCHEMBL7781880 | 0.78 | TDP1 (0.46) | TDP1TSHRALDH1A1 | |
| SCHEMBL7781883 | 0.78 | TDP1 (0.46) | TDP1TSHRALDH1A1HPGD | |
| SCHEMBL16897674 | 0.78 | ALOX15 (0.53) | ALOX15TSHRALDH1A1USP2GLA | |
| SCHEMBL16488808 | 0.78 | TDP1 (0.46) | TDP1TSHRALDH1A1HPGD | |
| SCHEMBL7191532 | 0.77 | TDP1 (0.45) | TDP1TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170275230-A1 | TERPENE-DERIVED ACIDS AND ESTERS AND METHODS FOR PREPARING AND USING SAME | P2 SCIENCE, INC. (US) | 2017-09-28 | — | — | US | disclosed |
| US-20170275230-A1 | TERPENE-DERIVED ACIDS AND ESTERS AND METHODS FOR PREPARING AND USING SAME | P2 SCIENCE, INC. (US) | 2017-09-28 | — | — | US | disclosed |
| US-9682914-B2 | Terpene-derived acids and esters and methods for preparing and using same | P2 SCIENCE, INC. (US) | 2017-06-20 | — | — | US | disclosed |
| US-9682914-B2 | Terpene-derived acids and esters and methods for preparing and using same | P2 SCIENCE, INC. (US) | 2017-06-20 | — | — | US | disclosed |
| US-20170113988-A1 | TERPENE-DERIVED COMPOUNDS AND METHODS FOR PREPARING AND USING SAME | P2 SCIENCE, INC. | 2017-04-27 | — | — | US | disclosed |
| US-20170113988-A1 | TERPENE-DERIVED COMPOUNDS AND METHODS FOR PREPARING AND USING SAME | P2 SCIENCE, INC. | 2017-04-27 | — | — | US | disclosed |
| US-20160332952-A1 | TERPENE-DERIVED ACIDS AND ESTERS AND METHODS FOR PREPARING AND USING SAME | P2 SCIENCE, INC. | 2016-11-17 | — | — | US | disclosed |
| US-20160332952-A1 | TERPENE-DERIVED ACIDS AND ESTERS AND METHODS FOR PREPARING AND USING SAME | P2 SCIENCE, INC. | 2016-11-17 | — | — | US | disclosed |
| WO-2015191706-A1 | TERPENE-DERIVED COMPOUNDS AND METHODS FOR PREPARING AND USING SAME | P2 SCIENCE, INC. (US) | 2015-12-17 | — | — | WO | disclosed |
| WO-2015106293-A1 | TERPENE-DERIVED ACIDS AND ESTERS AND METHODS FOR PREPARING AND USING SAME | P2 SCIENCE, INC. (US) | 2015-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160332952-A1 | TERPENE-DERIVED ACIDS AND ESTERS AND METHODS FOR PREPARING AND USING SAME | GGPS1, CYP51A1, LSS | ALOX15 56/4885TDP1 3561/4885TSHR 3593/4885 |
| US-20170113988-A1 | TERPENE-DERIVED COMPOUNDS AND METHODS FOR PREPARING AND USING SAME | MSMO1, ERG28, CYP51A1 | ALOX15 120/4885TDP1 3905/4885TSHR 3317/4885 |
| US-20170275230-A1 | TERPENE-DERIVED ACIDS AND ESTERS AND METHODS FOR PREPARING AND USING SAME | GGPS1, CYP51A1, LSS | ALOX15 56/4885TDP1 3561/4885TSHR 3593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.